Substance use and schizophrenia: adverse correlates in the CATIE study sample

Area of Science:

• Psychiatry
• Neuroscience
• Clinical Psychology

Background:

• Schizophrenia is frequently comorbid with substance use disorders.
• The impact of substance use severity on schizophrenia outcomes requires further investigation.

Purpose of the Study:

• To examine the relationship between the severity of illicit substance use at baseline and 18-month longitudinal outcomes in schizophrenia patients.
• To compare outcomes across groups with moderate/severe drug use, mild drug use, and no illicit substance use.

Main Methods:

• Utilized data from 1432 subjects in the Clinical Antipsychotic Trials of Intervention Effectiveness.
• Employed mixed-model analysis to compare outcomes over 18 months, controlling for baseline characteristics.
• Grouped subjects based on baseline illicit substance use severity: moderate/severe, mild, and non-users.

Main Results:

• Moderate/severe illicit drug users showed significantly poorer outcomes in psychosis, depression symptoms, and quality of life compared to mild users and non-users.
• No significant differences were found in neurocognitive functioning or employment days between the groups.
• Outcomes were assessed over an 18-month period.

Conclusions:

• The severity of illicit substance use, rather than use itself, is a critical factor in schizophrenia-related impairment.
• Highlights the necessity of thorough assessment and integrated treatment for substance abuse in schizophrenia.
• Harm reduction strategies integrated into long-term treatment may improve outcomes for dually diagnosed patients.